These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2781139)

  • 1. Studies on the mechanism of action of 1-(2-methyl-3-hydroxy-5-hydroxy-methyl-4-pyridyl)-6,7-dihydroxy-1,2,3, 4- tetrahydroisoquinoline (PTIQ) on blood pressure in the anesthetized dog.
    Siu PM; Vick JA
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):421-33. PubMed ID: 2781139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a central muscarinic action by 1-(2-methyl-3-hydroxy-5-hydroxymethyl-4-pyridyl)-6,7-dihydroxy-1,2, 3,4-tetrahydroisoquinoline in regulating blood pressure in the anesthetized dog.
    Siu PM; Vick JA
    Arch Int Pharmacodyn Ther; 1987 Jan; 285(1):43-9. PubMed ID: 3579425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a specific tetrahydroisoquinoline on the blood pressure in animals.
    Siu PM; Vick JA
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):203-8. PubMed ID: 4023409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
    Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M
    J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of 5-hydroxypropranolol (ORF 12592) in dogs.
    Ram N; Bauer EW; Hesse UC; Heilman RD
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):118-25. PubMed ID: 921395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and mechanism of action of trimazosin on coronary and left ventricular dynamics in conscious dogs.
    Macho P; Vatner SF
    J Pharmacol Exp Ther; 1981 May; 217(2):333-9. PubMed ID: 7229975
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of cocaine: enhancement by yohimbine and atropine.
    Wilkerson RD
    J Pharmacol Exp Ther; 1989 Jan; 248(1):57-61. PubMed ID: 2913288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the hypotensive and bradycardic effects of 1-piperidinylmethyl-2-naphthol hydrochloride.
    Shen AY; Huang MH; Wang TS
    Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):209-20. PubMed ID: 9467829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of myocardial contractility by a new cyclic nucleotide analog, 8-(benzylthio)-N6-n-butyladenosine cyclic 3',5'-phosphate (SQ 80122).
    Evans DB; Parham CS; Schenck MT; Laffan RJ
    J Cyclic Nucleotide Res; 1976 Jul-AUG; 2(4):307-19. PubMed ID: 184129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
    Chiba S; Malik KU
    J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effect of a naphthylmethyl substituted tetrahydroisoquinoline, YS 49, in rat and rabbit.
    Lee YS; Kim CH; Yun-Choi HS; Chang KC
    Life Sci; 1994; 55(21):PL415-20. PubMed ID: 7968232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central alpha receptors and their role in digoxin cardiotoxicity.
    Plunkett LM; Tackett RL
    J Pharmacol Exp Ther; 1983 Dec; 227(3):683-6. PubMed ID: 6317844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some aspects of pharmacological profile of sodium curcuminate.
    Rao TS; Basu N; Seth SD; Siddiqui HH
    Indian J Physiol Pharmacol; 1984; 28(3):211-5. PubMed ID: 6519763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
    Dage RC; Roebel LE; Hsieh CP; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.